-
Dizocilpine (INN), also
known as MK-801, is a pore
blocker of the NMDA receptor, a
glutamate receptor,
discovered by a team at
Merck in 1982. Glutamate...
- –
dizocilpine site
antagonist Dexanabinol –
dizocilpine-related site
antagonist Diethyl ether –
unknown site
antagonist Diphenidine –
dizocilpine site...
-
antagonists include ketamine, tiletamine, dextromethorphan,
nitrous oxide, and
dizocilpine (MK-801).
Research also
indicates that PCP
inhibits nicotinic acetylcholine...
-
selective and high-affinity NMDA
receptor antagonist,
specifically of the
dizocilpine (MK-801) site (Ki = 257 nM). It
produces ketamine-like effects. In addition...
-
workers had
recently begun proposing to use NMDA
antagonists PCP, MK-801 (
dizocilpine) and
ketamine in
clinical trials for
various psychological effects; but...
- Diphenidine: a
designer drug and PCP
analogue sold on the internet.
Dizocilpine (MK-801): an
experimental drug used in
scientific research. Ethanol:...
-
Ibotenic neurotoxicity can be
enhanced by
glycine and
blocked by
dizocilpine.
Dizocilpine acts as an
uncompetitive antagonist at NMDA receptors. Ibotenic...
- receptor. The S-(+) and R-(–)
stereoisomers of
ketamine bind to the
dizocilpine site of the NMDA
receptor with
different affinities, the
former showing...
- 83 nM. It
reverses the
amnesia induced by
drugs such as
scopolamine and
dizocilpine and
improves long-term
memory acquisition, but
inhibits short-term memory...
-
methoxetamine (MXE),
methoxphenidine (MXP) and
kynurenic acid.
While dizocilpine is
generally considered to be the
prototypical NMDA
receptor blocker...
